ReturnsPlannerReturnsPlanner
Quarterly Results
IPO Analysis
CalculatorsEditorial
India's Most Accurate Portfolio XIRR Calculator

Know Your True Returns.

Upload your Zerodha tradebook and get your real portfolio XIRR in seconds — with stock-wise breakdown, yearly charts, and deep analysis.

Why ReturnsPlanner XIRR?

Upload & Go

Drop your Zerodha CSV — multi-year support

Deep Analysis

Per-stock XIRR, yearly charts, P&L breakdown

100% Private

Your data never leaves your browser

Instant Results

No signup, no ads, no waiting

📊

Stock-wise XIRR

See annualized return for every stock you've traded — winners and losers at a glance

📈

Year-over-Year Charts

Visualize your investment pattern and returns with beautiful interactive charts

🔒

Zero Data Upload

Everything runs in your browser. We never see, store, or transmit your trade data

Financial Toolkit

SIP Calculator

PPF Calculator

EMI Calculator

RD Calculator

Income Tax Calculator

NPS Calculator

SSY Calculator

HRA Calculator

Daily Editorial & Market News

Bharat Forge's ₹450 Cr Write-Down vs. Defence Boom: What Indian Investors Need to Watch This Week
Market Analysis2026-05-07
Bharat Forge's ₹450 Cr Write-Down vs. Defence Boom: What Indian Investors Need to Watch This Week

Bharat Forge's recent quarterly loss, weighed down by a ₹450 crore write-down on its Tork Motors EV bet, requires investors to look past short-term noise and focus on the strong FY27 growth projections driven by defence orders.

Emami's ₹321 Cr Bet on Personalized Beauty: What Investors Must Watch This Week
Market Analysis2026-05-07
Emami's ₹321 Cr Bet on Personalized Beauty: What Investors Must Watch This Week

Emami is pivoting into high-growth personalized beauty through acquisitions like Vedix and SkinKraft, staking ₹321 crore on the future. With the stock at ₹456.35, investors must analyze if this strategic shift justifies the current underperformance.

FIIs/DIIs Net Buy ₹0 Cr on 7 May 2026: Does This Signal Market Pause or Deep Contemplation?
Institutional Activity2026-05-07
FIIs/DIIs Net Buy ₹0 Cr on 7 May 2026: Does This Signal Market Pause or Deep Contemplation?

On 7 May 2026, both FIIs and DIIs recorded a net buy of ₹0 Cr. This neutrality suggests institutional investors are in a phase of consolidation, awaiting clearer economic triggers ahead of the RBI meeting.

Market Results

BSE Q4 FY26 Results: PAT Jumps 61% YoY — Strong Operational Momentum?
Quarterly Results2026-05-07
BSE Q4 FY26 Results: PAT Jumps 61% YoY — Strong Operational Momentum?

BSE announced a stellar Q4 FY26 performance with Consolidated PAT soaring 61% to ₹797 crore, driven by exceptional revenue growth of 85%. Learn what this means for long-term investors.

Dabur India Q4 FY26 Results: PAT Rises 15% — Strong Domestic Resilience Confirmed?
Quarterly Results2026-05-07
Dabur India Q4 FY26 Results: PAT Rises 15% — Strong Domestic Resilience Confirmed?

Dabur India posted robust Q4 results with Cons PAT surging 15% YoY to Rs 369 crore, underpinned by strong domestic demand and the announcement of a final dividend of ₹5.50 per share.

MRF Q4 FY26 Results: Profit Jumps 37% YoY — Strong Finish, Dividend Declared?
Quarterly Results2026-05-07
MRF Q4 FY26 Results: Profit Jumps 37% YoY — Strong Finish, Dividend Declared?

MRF has announced exceptional Q4 results, with net profit soaring 37% YoY to ₹680 crore. The declaration of a substantial dividend adds significant positive momentum for investors.

IPO Analysis

Asian Footwear IPO: GMP, Price Band, Financials — Details & Review
IPO Analysis2026-05-07
Asian Footwear IPO: GMP, Price Band, Financials — Details & Review

Asian Footwear is doubling EBOs to 150 and targeting ₹1,000 crore revenue. Review the IPO details, GMP, and growth story of this value-driven player.

Tata Sons IPO: GMP, Price Band, Financials — Details & Review Amidst Conglomerate Pushback
IPO Analysis2026-05-07
Tata Sons IPO: GMP, Price Band, Financials — Details & Review Amidst Conglomerate Pushback

The Tata Sons IPO is nearing its listing phase, but internal differences regarding the timing have surfaced. Review the financial health and market sentiment driving this major corporate ascent.

Bagmane Prime Office REIT IPO: GMP, Price Band, Financials — Should You Apply?
IPO Analysis2026-05-06
Bagmane Prime Office REIT IPO: GMP, Price Band, Financials — Should You Apply?

Bagmane Prime Office REIT is currently accepting bids with a price range of ₹95 to ₹100, showing initial interest as it nears its closing date.

ReturnsPlanner

Your trusted partner for financial planning and wealth management.

Tools

  • XIRR Calculator ★
  • SIP Calculator
  • Retirement Planning
  • EMI Calculator

Analysis

  • Daily Editorial
  • IPO Analysis

Company

  • About Us
  • Contact
  • Privacy Policy

© 2025 ReturnsPlanner. All rights reserved.